Get the Daily Brief
Latest Biotech News
Enzyme conversion enables O kidneys — ABO‑incompatible transplant barrier lowered
Researchers reported an enzyme-conversion technique that transforms type O antigens on donor kidneys, enabling transplantation across ABO barriers. The protocol, tested in preclinical/early...
FAXP: Hydrogel expansion meets mass spec — spatial proteomics for FFPE tissue
A team introduced Filter‑aided expansion proteomics (FAXP), combining tissue expansion chemistry with mass spectrometry to profile proteins at high resolution in formalin‑fixed, paraffin‑embedded...
Sterility in 24 hours — accelerated test promises faster biopharma release
Scientists reported a validated sterility assay capable of returning results within a single day for biopharmaceutical products, potentially disrupting long lead times in lot release. The approach...
Antibody design overhauled: diffusion models and negative data reshape predictions
Two independent studies advanced computational antibody engineering: one presents an adaptive diffusion strategy to design humanized antibodies and nanobodies, and another demonstrates that...
Foundation models as pathology tools — weak supervision validated for slide analysis
Researchers evaluated foundation models as feature extractors in weakly supervised computational pathology and reported scalable performance on whole‑slide image tasks. Published in Nature...
Engineered T cells and synthetic APCs — new tools to boost immunotherapy potency
Two papers introduced complementary advances for T‑cell therapies: an overview of next‑generation engineered T cell platforms and a protocol for manufacturing synthetic viscoelastic...
Proteomics pinpoints cancer signatures — Mucin‑16 and exosome maps emerge
Two proteomics studies reported actionable molecular signatures: one used quantitative proteomics to characterize Mucin‑16 alterations in low‑grade serous ovarian cancer (Clinical Proteomics), and...
Regeneron to seek approval: gene therapy boosts hearing in children
Regeneron announced plans to pursue regulatory approval after publishing new data showing clinically meaningful hearing gains in children with a rare genetic deafness. The study, reported in The...
Sarepta files push: gene therapy shows target restoration in rare muscular dystrophy
Sarepta presented data showing its experimental gene therapy increased expression of the missing gene in patients with limb girdle muscular dystrophy (LGMD) 2E and said it plans to file for...
Novo shutters cell program – 250 jobs cut as CEO reshapes R&D
Novo Nordisk said it will discontinue its cell therapy R&D efforts and lay off nearly all of the roughly 250 employees working in the unit as part of a broader reorganization under new CEO Maziar...
Scale race in cell therapy: CAR‑iNK mass production and next‑gen engineered T cells
Researchers and companies reported two complementary advances aimed at scaling engineered immune-cell therapies. One team described methods to mass-produce CAR‑expressing natural killer (CAR‑iNK)...
Enzyme treatment enables ABO‑incompatible transplants: O kidneys now possible
A transplantation study reported successful conversion of donor blood group antigens using an enzymatic process that produced O-type kidneys eligible for broader use. The enzyme-conversion...
Proteomics goes clinical: tissue expansion method and lung‑nodule classifier
Two proteomics advances aim to accelerate clinical diagnostics. Researchers introduced FAXP (filter-aided expansion proteomics), a technique that combines hydrogel-based tissue expansion with mass...
High‑res brain interfaces: minimally invasive BCI and modular cortical arrays
Two neurotechnology teams unveiled complementary platforms for high-density brain interfacing. One group reported a scalable, minimally invasive, high-resolution brain-computer interface (BCI)...
Antibody AI: adaptive diffusion design and the need for negative data
Computational antibody design advanced on two fronts: an adaptive diffusion strategy for humanizing and designing therapeutic antibodies and a separate study highlighting the essential role of...
AI accelerates protein engineering: generative models meet structure
AI-driven protein engineering shows fresh momentum with demonstrations that foundation models and sparse denoising architectures can both speed structure generation and guide functional protein...
Mass layoffs at HHS and CDC turmoil: federal public‑health workforce slashed
Two related reports documented sweeping personnel actions that disrupted federal public-health capacity. One account described overnight notices that more than 1,000 HHS and CDC staffers were...
Regeneron to seek approval after hearing‑loss gene therapy shows gains
Regeneron announced plans to seek regulatory approval after publication of New England Journal of Medicine data showing a gene therapy produced significant hearing improvement in nearly a dozen...
Sarepta moves to file first LGMD gene therapy – therapy raises missing‑gene levels
Sarepta Therapeutics said new clinical results showed its experimental gene therapy increased expression of the missing protein in an ultra‑rare form of limb‑girdle muscular dystrophy (LGMD2E) and...
Chiesi inks CRISPR deal for rare liver disease; study suggests anti‑AAV antibodies may not block therapy
Chiesi Global Rare Diseases committed up to $115 million in a collaboration with CRISPR startup Arbor Biotechnologies to develop an in vivo gene‑editing therapy for primary hyperoxaluria type 1,...